Last Updated :2023/01/06

Affiliations, Positions
Hiroshima University Hospital(Medical), Assistant Professor
Web Site
Elucidation of the molecular mechanisms of Aldosterone synthesis and tumor formation in aldosterone-producing adenomas, the cause of primary aldosteronism.

Basic Information

Major Professional Backgrounds

  • 2022/04/01, Hiroshima University, Hospital, Assistant Professor

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical & Health Sciences , Japan, 2018/04, 2022/03

Academic Degrees

  • Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Endocrinology

Research Keywords

  • primary aldosteronism
  • Cushing's syndrome
  • cortisol
  • Aldosterone
  • adrenal gland

Affiliated Academic Societies

  • The Japan Society of Internal Medicine
  • The Japan Endocrine Society
  • The Japan Diabetes Society

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2022, Undergraduate Education, First Semester, Internalz Medicine II

Research Activities

Academic Papers

  1. Measurement of midnight ACTH levels is useful for the evaluation of midnight cortisol levels, STEROIDS, 140, 179-184, 20190104
  2. Association of DNA methylation with steroidogenic enzymes in Cushing's adenoma, ENDOCRINE-RELATED CANCER, 29(8), 459-502, 20221014
  3. Angiotensin-converting enzyme 2 expression is not induced by the renin-angiotensin system in the lung, ERH OPEN RESEARCH, 6(4), 20210120
  4. ATP1A1Mutant in Aldosterone-Producing Adenoma Leads to Cell Proliferation, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(20), 20211115
  5. Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma

  6. ★, Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations, Molecular and Cellular Endocrinology, 20211010
  7. Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production, HYPERTENSION, 75(2), 492-499, 20200206

External Funds

Acceptance Results of Competitive Funds

  1. 2022, 2023